Nefrología e Hipertensión, Patología Vascular y Diabetes

Resumen de actividad

La enfermedad renal crónica (ERC) será la quinta causa de muerte en el mundo (tercera en España) en 2050 y la segunda en España en 2100. El grupo de Nefrología e Hipertensión, Patología Vascular, y Diabetes aborda las causas y consecuencias de la enfermedad renal, con especial énfasis en la diabetes y enfermedades glomerulares y familiares como causas, y la hipertensión y la enfermedad cardiovascular, como consecuencias.

Contribuciones a la sociedad

El grupo colabora con asociaciones de pacientes nacionales (ALCER) e internacionales (European Kidney Patient’s Federation) para mejorar la prevención, diagnóstico y tratamiento de la diabetes y de las enfermedades renales y cardiovasculares, a través de publicaciones (>1000 citadas >200 000 veces), guías clínicas (>10) y patentes (>10), actividades en Sociedades y congresos científicas y actividades educativas (MOOC renal: https://www.edx.org/course/rinones-conoce-sus-funciones-para-mejorar-tu-salud).

Colaboraciones

El grupo tiene múltiples colaboraciones nacionales e internacionales en el contexto de proyecto del Plan Nacional, de la Unión Europea o de grupos de trabajo dentro de Sociedades científicas nacionales o internacionales. Así, desde el IIS-FJD se coordina la Red de Investigación Renal del ISCIII (antes RETIC REDINREN, ahora RICORS2040), porque su objetivo es evitar que se cumplan las proyecciones sobre la mortalidad de causa renal en España para 2040.

Tesis doctorales

04-RENALES-Nefrologia-tesis

Relación de publicaciones ordenadas por fecha de publicación

Body composition and CO2 dietary emissions.

García S, Monserrat-Mesquida M, Mas-Fontao S, Cuadrado-Soto E, Ortiz-Ramos M, Matía-Martín P, Daimiel L, Vázquez C, Tur JA, Bouzas C.

Front Public Health. eCollection 2024. 2025 Jan 17;12:1432109.

PMID: 39897182

FI: 3

Metabolomics to Identify Unclassified Uremic Toxins: A Comprehensive Literature Review.

Vanholder R, Glorieux G, Argiles A, Burtey S, Cohen G, Duranton F, Koppe L, Massy ZA, Ortiz A, Masereeuw R, Stamatialis D, Jankowski J.

Kidney Med. 2024 Dec 26;7(3):100955.

PMID: 39980938

FI: 3,2

How to improve the environmental impact in haemodialysis: small actions, big changes.

Jiménez MDA, Audije-Gil J, Martínez R, Martín Vaquero N, Gómez M, Portillo J, Pereda G, Gascueña DH, Duane B, Sanjuan M, Martín JLF, Dapena F, Ortiz A, Arias M.

Clin Kidney J. 2024 Dec 20;18(2):sfae407.

PMID: 39927256

FI: 3,9

Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease.

Lumpuy-Castillo J, Rupérez FJ, Porto BLS, Cristóbal C, Tarín N, Huelmos AI, Alonso J, Egido J, Mahíllo-Fernández I, López-Bescós L, Tuñón J, Lorenzo Ó.

Biomolecules. 2024 Dec 29;15(1):27.

PMID: 39858422

FI: 4,8

Beyond secondary prevention drugs: Added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome.

Rodríguez EC, Kallmeyer A, Tarín N, Cristóbal C, Huelmos A, Lázaro AMP, Aceña Á, Gutiérrez-Landaluce C, González-Lorenzo Ó, Lumpuy-Castillo J, Alonso J, López-Bescós L, Egido J, Lorenzo Ó, Blanco-Colio LM, Tuñón J.

Am J Prev Cardiol. 2024 Dec 22;21:100923.

PMID: 39834624

FI: 4,4

Prospective association of changes in (poly)phenol intake, body weight and physical activity with inflammatory profile.

Rubín-García M, Vitelli-Storelli F, Álvarez-Álvarez L, Fitó M, Vázquez-Ruiz Z, Salas-Salvadó J, Corella D, Serra-Majem L, Warnberg J, Romaguera D, Estruch R, Pintó X, Martínez JA, Vázquez C, Vidal J, Tur JA, Alonso-Gómez ÁM, Ros E, Vioque J, López-Miranda J, Bueno-Cavanillas A, Tinahones FJ, Lapetra J, Daimiel L, Delgado-Rodríguez M, Matía-Martín P, Babio N, Schröder H, Lamuela-Raventós RM, Martín-Sánchez V, Zamora-Ros R.

Nutr Metab Cardiovasc Dis. 2024 Dec 20:103837.

PMID: 39800617

FI: 3,3

Acrylamide Exposure and Cardiovascular Risk: A Systematic Review.

Mérida DM, Rey-García J, Moreno-Franco B, Guallar-Castillón P.

Nutrients. 2024 Dec 11.16(24).

PMID: 39770901

FI: 4,8

International Nephrology Masterclass in Chronic Kidney Disease: Rationale, Summary, and Future Perspectives.

Pesce F, Vadalà M, Almeida E, Fernandez B, Fouque D, Malyszko J, Schmidt-Ott K, Stenvinkel P, Wheeler DC, Seidu S, Cebrian A, Dimov N, Pardo MB, Ziedina I, Habashi N, Manrique J, Marques SHM, Gallardo MAV, Shehaj L, Nikolova Vlahova MK, Mendonça L, Ksiazek S, Veltri P, Pezzi G, Patella G, Borelli G, Provenzano M, Gesualdo L.

Life (Basel). 2024 Dec 17.14(12).

PMID: 39768375

FI: 3,2

Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes.

Zannad F, McGuire DK, Ortiz A.

J Intern Med. 2024 Dec 31.

PMID: 39739537

FI: 9

ERA Registry Figure of the month The prevalence of kidney replacement therapy in Europe and the United States.

Stel VS, Ortiz A, Kramer A.

Clin Kidney J. 2024 Dec.17(12):sfae372.

PMID: 39717419

FI: 3,9

Biomarkers of oxidation, inflammation and intestinal permeability in persons with diabetes mellitus with parenteral nutrition: A multicenter randomized trial.

Soria-Utrilla V, Sasso CV, Romero-Zerbo SY, Adarve-Castro A, López-Urdiales R, Herranz-Antolín S, García-Almeida JM, García-Malpartida K, Ferrer-Gómez M, Moreno-Borreguero A, Luengo-Pérez LM, Álvarez-Hernández J, Aragón-Valera C, Ocón-Bretón MJ, García-Manzanares Á, Bretón-Lesmes I, Serrano-Aguayo P, Pérez-Ferre N, López-Gómez JJ, Olivares-Alcolea J, Moreno-Martínez M, Tejera-Pérez C, García-Arias S, Abad-González ÁL, Alhambra-Expósito MR, Zugasti-Murillo A, Parra-Barona J, Torrejón-Jaramillo S, Abuin J, Fernández-García JC, Olveira G, Nutrition Area of the Spanish Society of Endocrinology and Nutrition (SEEN).

Clin Nutr. 2025 Jan.44:155-164.

PMID: 39672082

FI: 6,6

Global, regional, and national progress towards the 2030 global nutrition targets and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021.

Global Nutrition Target Collaborators (Collaborator: Ortiz A).

Lancet. 2025 Dec 21.404(10471):2543-2583.

PMID: 39667386

FI: 98,4

Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis.

Navarro-González JF, Ortiz A, Cebrián Cuenca A, Segú L, Pimentel B, Aranda U, Lopez-Chicheri B, Capel M, Pomares Mallol E, Caudron C, García Sánchez JJ, Alcázar Arroyo R.

Nefrologia (Engl Ed). 2024.44(6):857-867.

PMID: 39645514

FI: 2

Environmental challenges in hemodialysis: Exploring the road to sustainability.

Arias-Guillén M, Martínez Cadenas R, Gómez M, Martín Vaquero N, Pereda G, Audije-Gil J, Portillo J, Quintela M, Castaño I, Luque A, Maduell F, Ortiz A, Duane B, Arenas MD, en representación del Grupo de Trabajo de Hemodiálisis en Centro de la Sociedad Española de Nefrología y del Grupo de Trabajo de Sostenibilidad en Nefrología.

Nefrologia (Engl Ed). 2024.44(6):784-795.

PMID: 39645513

FI: 2

Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology.

Cases A, Broseta JJ, Marqués M, Cigarrán S, Julián JC, Alcázar R, Ortiz A.

Nefrologia (Engl Ed). 2024.44(6):771-783.

PMID: 39645511

FI: 2

The global, regional, and national burden of urolithiasis in 204 countries and territories, 2000-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Urolithiasis Collaborators (Collaborator: Ortiz A).

EClinicalMedicine. 2024 Dec.78:102924.

PMID: 39640943

FI: 9,6

Prevalence and factors linked to renal involvement in prediabetes patients across Europe in the ePREDICE trial.

Mas-Fontao S, Civantos E, Boukichou N, Moreno JA, Tuomilehto J, Gabriel R, Egido J.

Sci Rep. 2024 Dec 05.14(1):30336.

PMID: 39638835

FI: 3,8

Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project.

Navarro González JF, Ortiz A, Cebrián Cuenca A, Moreno Barón M, Segú L, Pimentel B, Aranda U, Lopez-Chicheri B, Capel M, Pomares Mallol E, Caudron C, García Sánchez JJ, Alcázar Arroyo R.

Nefrologia (Engl Ed). 2024.44(6):807-817.

PMID: 39632193

FI: 2

Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?

Theodorakopoulou M, Ortiz A, Fernandez-Fernandez B, Kanbay M, Minutolo R, Sarafidis PA.

Clin Kidney J. 2024 Dec.17(Suppl 2):36-50.

PMID: 39583143

FI: 3,9

GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesity.

Abasheva D, Ortiz A, Fernandez-Fernandez B.

Clin Kidney J. 2024 Dec.17(Suppl 2):19-35.

PMID: 39583142

FI: 3,9

Runt-related transcription factor 1 (RUNX1) is a mediator of acute kidney injury.

Fontecha-Barriuso M, Villar-Gomez N, Guerrero-Mauvecin J, Martinez-Moreno JM, Carrasco S, Martin-Sanchez D, Rodríguez-Laguna M, Gómez MJ, Sanchez-Niño MD, Ruiz-Ortega M, Ortiz A, Sanz AB.

J Pathol. 2024 Dec.264(4):396-410.

PMID: 39472111

FI: 5,6

REAL life study of subcutaneous SEMaglutide in patients with type 2 diabetes in SPain: Ambispective, multicenter clinical study. Results in the GLP1-experienced cohort.

Cárdenas-Salas JJ, Sierra Poyatos RM, Luca BL, Sánchez Lechuga B, Modroño Móstoles N, Montoya Álvarez T, Gómez Montes MP, Ruiz Sánchez JG, Meneses González D, Sánchez-Lopez R, Casado Cases C, Pérez de Arenaza Pozo V, Vázquez Martínez C.

J Diabetes Complications. 2024 Dec.38(12):108874.

PMID: 39442257

FI: 2,9

Higher neighborhood disadvantage is associated with weaker interactions among cardiometabolic drivers.

Hernandez Sevillano J, Babagoli MA, Chen Y, Liu SH, Mellacheruvu P, Johnson J, Ibanez B, Lorenzo O, Mechanick JI.

Int J Cardiol Cardiovasc Risk Prev. 2024 Dec.23:200322.

PMID: 39282603

FI: 1,9

Acute kidney injury following CAR-T cell therapy: a nephrologist's perspective.

Kanbay M, Mizrak B, Alper EN, Copur S, Ortiz A.

Clin Kidney J. 2024 Nov 15;18(1):sfae359.

PMID: 39781479

FI: 3,9

Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus.

Perez de Arenaza Pozo V, Cárdenas Salas J, Vázquez Martínez C.

Endocrinol Diabetes Nutr (Engl Ed). 2024 Nov.71(9):405-407.

PMID: 39608966

FI: 1,8

ERA Registry Figure of the month Heterogeneity of kidney replacement therapy incidence across Europe.

Stel VS, Ortiz A, Kramer A.

Clin Kidney J. 2024 Nov.17(11):sfae306.

PMID: 39605950

FI: 3,9

Identification and study of new NF-κB-inducing kinase ligands derived from the imidazolone scaffold.

Maqueda-Zelaya F, Valiño-Rivas L, Milián A, Gutiérrez S, Aceña JL, Garcia-Marin J, Sánchez-Niño MD, Vaquero JJ, Ortiz A.

Arch Pharm (Weinheim). 2025 Jan.358(1):e2400614.

PMID: 39604268

FI: 4,3

Roxadustat Efficacy and Safety in Patients Receiving Peritoneal Dialysis: Pooled Analysis of Four Phase 3 Studies.

Fliser D, Bhandari S, Ortiz A, Santos V, Khalife N, Jiletcovici A, Akizawa T.

J Clin Med. 2024 Nov 08.13(22).

PMID: 39597872

FI: 3

Influence of smoking on cardiometabolic profile and surgical outcomes in patients with primary aldosteronism: a cohort study.

Araujo-Castro M, Paja Fano M, González-Boillos M, Pascual-Corrales E, Parra Ramírez P, Martín Rojas-Marcos P, García-Cano A, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Casterás A, Puig-Perez A, García Sanz I, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo C, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, María Recio J, Morales-Ruiz M, Calatayud M, Jiménez López N, Meneses D, Sampedro Nuñez M, Ribas EM, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Del Castillo Tous M, Serrano J, Michalopoulou T, Tenes Rodrigo S, Roa Chamorro R, Jaén Aguila F, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA.

Eur J Endocrinol. 2024 Nov 27.191(6):579-587.

PMID: 39556770

FI: 5,3

Upper extremity deep vein thrombosis in hospitalized central venous catheter carriers and non-carriers: A retrospective cohort study.

Novalbos-Partida JÁ, Rueda-Camino JA, Angelina-García M, Joya-Seijo MD, Trujillo-Luque D, Barba-Martín R.

Med Clin (Barc). 2024 Nov 11.

PMID: 39532583

FI: 2,6

Are More Patients with Thromboembolic Disease Dying Now Than Before?

Barba R.

Thromb Haemost. 2024 Nov 11.

PMID: 39529311

FI: 5

Cefadroxil Targeting of SLC15A2/PEPT2 Protects From Colistin Nephrotoxicity.

Fernandez-Prado R, Valiño L, Pintor-Chocano A, Sanz AB, Ortiz A, Sanchez-Niño MD.

Lab Invest. 2024 Nov 08.105(1):102182.

PMID: 39522761

FI: 5,1

Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach.

Duane B, Steinbach I, Stancliffe R, Barna S, Cameron D, de Barbieri I, Noruisiene E, Mortimer F, Gerritsen K, Vanholder R, Donati G, Alfano G, Malyszko J, Ligabue G, Johnston B, Wratten ML, Caiazzo M, Schmid E, Ortiz A.

J Nephrol. 2024 Nov 08.

PMID: 39511063

FI: 2,7

Is it possible to reach the catheter target proposed by the guidelines? Reasons for catheter use in prevalent hemodialysis patients.

Arenas MD, Cazar R, Cordón A, Méndez A, Acuña M, Furaz K, Hernan D, Manso P, Dapena F, Rosiqué F, Martinez L, Andúgar L, Picasso ML, Santos-Ascarza JL, Hernández A, González-Parra E, Sanchez-Tocino ML, Grupo de trabajo Fundación renal.

Nefrologia (Engl Ed). 2024.44(5):700-708.

PMID: 39510894

FI: 2

Risk factors for progression in patients with KDOQI stage 3 Chronic Kidney Disease (PROGRESER study).

Martínez-Castelao A, Górriz Teruel JL, D'Marco L, Garrigós E, Fernández-Fresnedo G, Espinel Garuz E, Cigarrán Guldris S, Coloma JA, Robles Pérez-Monteoliva NR, Esteban de la Rosa JR, Nieto Iglesias LJ, Ortiz Arduán A, Navarro-González JF, PROGRESER study investigators, GEENDIAB (Spanish Group for the Study of Diabetic Nephropathy).

Nefrologia (Engl Ed). 2024.44(5):689-699.

PMID: 39510892

FI: 2

Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study.

Ortiz A, Kramer A, Ariceta G, Rodríguez Arévalo OL, Gjerstad AC, Santiuste C, Trujillo-Alemán S, Ferraro PM, Methven S, Santamaría R, Naumovic R, Resic H, Hommel K, Segelmark M, Ambühl PM, Sorensen SS, Parmentier C, Vidal E, Bakkaloglu SA, Plumb L, Palsson R, Kerschbaum J, Ten Dam MAGJ, Stel VS, Jager KJ, Torra R.

Nephrol Dial Transplant. 2024 Nov 06.

PMID: 39508350

FI: 4,8

Nox4 is involved in acute kidney injury associated to intravascular hemolysis.

García-Caballero C, Guerrero-Hue M, Vallejo-Mudarra M, Palomino Antolin A, Decouty-Pérez C, Sánchez-Mendoza LM, Villalba JM, González-Reyes JA, Opazo-Rios L, Vázquez-Carballo C, Herencia C, Leiva-Cepas F, Cortegano I, Andrés B, Egido J, Egea J, Moreno JA.

Free Radic Biol Med. 2024 Nov 20.225:430-444.

PMID: 39413979

FI: 7,1

Impact of Cortisol-Cosecretion on Adrenal Venous Sampling Results in Primary Aldosteronism: Study of 225 Cases.

Lamas C, Araujo-Castro M, Ostermair L, Petersenn E, Parra Ramírez P, Rebollo-Román Á, Stuefchen I, Bruedgam D, Ruiz-Sanchez JG, Michalopoulou T, Perdomo CM, Hanzu FA, Adolf C, Reincke M.

Biomedicines. 2024 Oct 23.12(11).

PMID: 39594996

FI: 3,9

NIK Is a Mediator of Inflammation and Intimal Hyperplasia in Endothelial Denudation-Induced Vascular Injury.

Baeza C, Ribagorda M, Maya-Lopez C, Fresno M, Sanchez-Diaz T, Pintor-Chocano A, Sanz AB, Carrasco S, Ortiz A, Sanchez-Niño MD.

Int J Mol Sci. 2024 Oct 25.25(21).

PMID: 39519026

FI: 4,9

Proceedings of a membrane update symposium: advancements, scientific insights, and future trends for dialysis membranes for enhanced clinical outcomes in end stage kidney disease patients.

Wanner C, Vanholder R, Ortiz A, Davenport A, Canaud B, Blankestijn PJ, Masereeuw R, Kooman JP, Castellano G, Stamatialis D, Mitra S, Grooteman M, Weber V, Ebert T, Abdelrasoul A, Steppan S, Scheiwe AR, Stenvinkel P.

Front Nephrol. 2024.4:1455260.

PMID: 39473870

FI: 0

Translational research on cognitive impairment in chronic kidney disease.

Wagner CA, Massy ZA, Capasso G, Mattace-Raso F, Pepin M, Bobot M, Zoccali C, Ferreira AC, Hoorn EJ, Silva PHI, Unwin RJ, Pesic V, CONNECT (Collaborator: Ortiz A).

Nephrol Dial Transplant. 2024 Oct 14.

PMID: 39400744

FI: 4,8

Hospital admissions for pyoderma gangrenosum in Spain (1999-2021): Epidemiological and clinical characteristics, temporal trends, and factors associated with poor prognosis and higher cost.

Belinchón-Romero I, Sánchez-Martínez V, Ramos-Belinchón C, Ramos-Rincón JM.

Health Sci Rep. 2024 Oct.7(10):e2286.

PMID: 39381532

FI: 2,1

Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Stroke Risk Factor Collaborators (Collaborator: Ortiz A).

Lancet Neurol. 2024 Oct.23(10):973-1003.

PMID: 39304265

FI: 46,6

Role of mitochondria in reno-cardiac diseases: A study of bioenergetics, biogenesis, and GSH signaling in disease transition.

Lumpuy-Castillo J, Amador-Martínez I, Díaz-Rojas M, Lorenzo O, Pedraza-Chaverri J, Sánchez-Lozada LG, Aparicio-Trejo OE.

Redox Biol. 2024 Oct.76:103340.

PMID: 39250857

FI: 10,7

Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.

Ruiz-Sanchez JG, Fernandez Sanchez Á, Cardenas-Salas J, Fernandez-Cagigao Y, Alegre Bellassai ER, Rossello MG, Fernandez-Fernandez B, Jimenez Moreno B, Paniagua A, Vazquez C, Meneses D.

J Hypertens. 2024 Oct 01.42(10):1813-1822.

PMID: 39196692

FI: 3,3

Impact of primary aldosteronism on kidney function: results from the SPAIN-ALDO registry.

Araujo-Castro M, Paja Fano M, González-Boillos M, Pascual-Corrales E, Martín Rojas-Marcos P, García-Cano A, Ruiz-Sanchez JG, Vicente A, Gómez-Hoyos E, Casterás A, Puig-Pérez A, García Sanz I, Recasens M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román A, Robles Lázaro C, María Recio J, Morales-Ruiz M, Calatayud M, Jiménez López N, Meneses D, Sampedro Nuñez M, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Castillo Tous MD, Serrano J, Michalopoulou T, Tenés Rodrigo S, Roa Chamorro R, Jaén Aguila F, Moya Mateo EM, Gutiérrez-Medina S, Hanzu FA, Parra Ramírez P.

J Hypertens. 2024 Oct 01.42(10):1805-1812.

PMID: 39051487

FI: 3,3

Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study.

Rodríguez-Miguel A, Fernández-Fernández B, Ortiz A, Gil M, Rodríguez-Martín S, Ruiz-Hurtado G, Fernández-Antón E, Ruilope LM, de Abajo FJ.

Pharmaceuticals (Basel). 2024 Sep 29.17(10).

PMID: 39458940

FI: 4,3

Elevated plasma levels of TNF-R1 predict the development of acute ischemic events in coronary patients with diabetes.

Mas-Fontao S, Tarín N, Cristóbal C, Soto-Catalán M, Pello A, Aceña A, Lumpuy-Castillo J, Garces C, Gomez-Guerrero C, Gutiérrez-Landaluce C, Blanco-Colio LM, Martín-Ventura JL, Huelmos A, Alonso J, López Bescós L, Moreno JA, Mahíllo-Fernández I, Lorenzo Ó, González-Casaus ML, Egido J, Tuñón J.

Clin Investig Arterioscler. 2024 Sep 28.

PMID: 39343690

FI: 1,9

A Multiplexed Quantitative Proteomics Approach to the Human Plasma Protein Signature.

Núñez E, Gómez-Serrano M, Calvo E, Bonzon-Kulichenko E, Trevisan-Herraz M, Rodríguez JM, García-Marqués F, Magni R, Lara-Pezzi E, Martín-Ventura JL, Camafeita E, Vázquez J.

Biomedicines. 2024 Sep 18.12(9).

PMID: 39335631

FI: 3,9

ASSESSMENT OF 1-HOUR POST-LOAD PLASMA GLUCOSE, THE METABOLIC SYNDROME AND THE FINDRISC SCORE IN THE PREDICTION OF TYPE 2 DIABETES.

Lizarzaburu-Robles JC, Garro-Mendiola A, Lazo-Porras M, Sanz-Pastor AG, Vento F, Lorenzo O.

Endocr Pract. 2024 Sep 25.

PMID: 39332500

FI: 3,7

Sex-specific dietary patterns and their association with metabolic syndrome: Insights from a cross-sectional analysis.

Popescu ML, Rubín-García M, Álvarez-Álvarez L, Toledo E, Corella D, Salas-Salvadó J, Pérez-Vega KA, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Cano-Ibáñez N, Tur JA, Naveiro R, Pintó X, Delgado-Rodríguez M, Ortiz-Ramos M, Vidal J, Vázquez C, Daimiel L, Ros E, Vázquez-Ruiz Z, Babio N, Sorlí JV, Castañer O, García-Rios A, González-Palacios S, Zulet M, Konieczna J, Casas R, Masso-Guijarro P, Tojal-Sierra L, Gómez-Pérez AM, Cenoz-Osinaga JC, Valverde I, Fernández-Carrión R, Schröder H, Arenas Larriva AP, Torres-Collado L, García-Arellano A, Palau-Galindo A, Fitó M, Martín-Sánchez V, Fernández-Villa T.

Diabetes Metab Syndr. 2024 Sep 24.18(9):103123.

PMID: 39326341

FI: 4,3

Ccn2 Deletion Reduces Cardiac Dysfunction, Oxidative Markers, and Fibrosis Induced by Doxorubicin Administration in Mice.

Tejera-Muñoz A, Cortés M, Rodriguez-Rodriguez A, Tejedor-Santamaria L, Marchant V, Rayego-Mateos S, Gimeno-Longas MJ, Leask A, Nguyen TQ, Martín M, Tuñón J, Rodríguez I, Ruiz-Ortega M, Rodrigues-Díez RR.

Int J Mol Sci. 2024 Sep 05.25(17).

PMID: 39273564

FI: 4,9

Barriers and Strategies to Optimize the Use of Glucagon-Like Peptide 1 Receptor Agonists in People with Type 2 Diabetes and High Cardiovascular Risk or Established Cardiovascular Disease: A Delphi Consensus in Spain.

Botana López M, Camafort Babkowski M, Campuzano Ruiz R, Cebrián Cuenca A, Gargallo Fernández M, David de Paz H, Redondo-Antón J, Artime E, Díaz-Cerezo S, Rubio de Santos M.

Adv Ther. 2024 Sep.41(9):3569-3584.

PMID: 39039388

FI: 3,4

The impact of population ageing on the burden of chronic kidney disease.

Chesnaye NC, Ortiz A, Zoccali C, Stel VS, Jager KJ.

Nat Rev Nephrol. 2024 Sep.20(9):569-585.

PMID: 39025992

FI: 28,7

Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study.

Camblor Blasco A, Devesa A, Nieto Roca L, Gómez-Talavera S, Lumpuy-Castillo J, Pello Lázaro AM, Llanos Jiménez L, Sánchez González J, Lorenzo Ó, Tuñón J, Ibáñez B, Aceña Á.

J Clin Med. 2024 Aug 25.13(17).

PMID: 39274245

FI: 3

Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysis.

Bonomini M, Davies S, Kleophas W, Lambie M, Reboldi G, Liberato LD, Divino-Filho JC, Heimburger O, Ortiz A, Povlsen J, Iacobelli M, Prosdocimi T, Arduini A.

Perit Dial Int. 2024 Aug 28:8968608241274106.

PMID: 39205396

FI: 2,7

Objectively Measured Sleep Duration and Health-Related Quality of Life in Older Adults with Metabolic Syndrome: A One-Year Longitudinal Analysis of the PREDIMED-Plus Cohort.

Marcos-Delgado A, Martín-Sánchez V, Martínez-González MÁ, Corella D, Salas-Salvadó J, Schröder H, Martínez A, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Santos-Lozano JM, Álvarez-Pérez J, Bueno-Cavanillas A, Cano-Ibáñez N, Amezcua-Prieto C, Hernández-Segura N, Tur JA, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Toledo E, Garcidueñas-Fimbres TE, Viaplana J, Asensio EM, Zomeño MD, Garcia-Rios A, Oncina-Cánovas A, Barón-López FJ, Pérez-Farinos N, Sayon-Orea C, Galmés-Panadés AM, Casas R, Tojal-Sierra L, Gómez-Pérez AM, Buil-Corsiales P, García-Gavilán JF, Ortega-Azorín C, Castañer O, Peña-Orihuela PJ, González-Palacios S, Babio N, Fitó M, Nieto J.

Nutrients. 2024 Aug 09.16(16).

PMID: 39203769

FI: 4,8

Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort.

Rojas-Rivera JE, Hasegawa T, Fernandez-Juarez G, Praga M, Saruta Y, Fernandez-Fernandez B, Ortiz A, Sysmex R&D Center Europe team and STARMEN working group .

Clin Kidney J. 2024 Aug.17(8):sfae239.

PMID: 39188767

FI: 3,9

Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.

Montez de Sousa IR, Bonthuis M, Kramer A, Ordoñez FA, de la Cerda Ojeda F, Rydell H, Helve J, Groothoff JW, Hommel K, Buchwinkler L, Segelmark M, Arici M, Palsson R, Bell S, Trujillo-Alemán S, Bakkaloglu SA, Sørensen SS, Vila A, Ortiz A, Stel VS, Jager KJ.

Nephrol Dial Transplant. 2024 Aug 24.

PMID: 39182157

FI: 4,8

Smooth muscle-specific deletion of Ccn2 causes severe aorta malformation and atherosclerosis.

Larsen JH, Hegelund JS, Pedersen MK, Andersson CM, Lindegaard CA, Hansen DR, Stubbe J, Lindholt JS, Hansen CS, Grentzmann A, Bloksgaard M, Jensen BL, Rodriguez-Díez RR, Ruiz-Ortega M, Albinsson S, Pasterkamp G, Mokry M, Leask A, Goldschmeding R, Pilecki B, Sorensen GL, Pyke C, Overgaard M, Beck HC, Ketelhuth DFJ, Rasmussen LM, Steffensen LB.

Cardiovasc Res. 2024 Aug 21.

PMID: 39167826

FI: 10,4

Does amino acid infusion improve kidney outcomes in patients at high risk for postsurgical AKI?

Faguer S, Selby NM, Seigneux SDE, Cantaluppi V, Gameiro J, Lopes JA, Malyszko J, Belen Sanz A, Saritas T, Ostermann M.

Nephrol Dial Transplant. 2024 Aug 12.

PMID: 39134507

FI: 4,8

Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.

Liabeuf S, Hafez G, Pešić V, Spasovski G, Bobot M, Mačiulaitis R, Bumblyte IA, Ferreira AC, Farinha A, Malyszko J, Pépin M, Massy ZA, Unwin R, Capasso G, Mani LY, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) (Collaborator: Ortiz A).

Clin Kidney J. 2024 Aug.17(8):sfae174.

PMID: 39114495

FI: 3,9

Proteomic analysis of endothelial cells and extracellular vesicles in response to indoxyl sulfate: Mechanisms of endothelial dysfunction in chronic kidney disease.

Figuer A, Santos FM, Ciordia S, Valera G, Martín-Jouve B, Hernández-Fonseca JP, Bodega G, Ceprián N, Ramírez R, Carracedo J, Alique M.

Life Sci. 2024 Aug 15.351:122810.

PMID: 38871114

FI: 5,2

A Randomized Controlled Clinical Trial Testing Effects of Lademirsen on Kidney Function Decline in Adults with Alport Syndrome.

Gale DP, Gross O, Wang F, Esteban de la Rosa RJ, Hall M, Sayer JA, Appel G, Hariri A, Liu S, Maski M, Shen Y, Zhang Q, Iqbal S, Kowthalam MU, Lin J, Ding J, HERA Clinical Trial Group (Collaborator: Ortiz A).

Clin J Am Soc Nephrol. 2024 Aug 01.19(8):995-1004.

PMID: 38829703

FI: 8,5

Boldine prevents the inflammatory response of cardiac fibroblasts induced by SGK1-NFκB signaling pathway activation.

Catalán M, González-Herrera F, Maya JD, Lorenzo O, Pedrozo Z, Olmedo I, Suarez-Rozas C, Molina-Berrios A, Díaz-Araya G, Vivar R.

Cell Signal. 2024 Aug.120:111241.

PMID: 38825173

FI: 4,4

Complete Description of the Three Pathways of the Complement System in a Series of 430 Patients with Rheumatoid Arthritis.

Rodríguez-González D, García-González M, Gómez-Bernal F, Quevedo-Abeledo JC, González-Rivero AF, Fernández-Cladera Y, González-López E, Ocejo-Vinyals JG, Jiménez-Sosa A, González-Toledo B, González-Gay MÁ, Ferraz-Amaro I.

Int J Mol Sci. 2024 Jul 31.25(15).

PMID: 39125933

FI: 4,9

COVID-19 and Cognitive Decline in Older Adults with High-Cardiovascular Risk: A Post Hoc Analysis.

Shyam S, Gómez-Martínez C, Ni J, Gaforio JJ, Martínez-González MÁ, Corella D, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Martín-Sánchez V, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Fernandez-Aranda F, Hernández-Cacho A, Buil-Cosiales P, Sorli JV, Castañer O, Garcia-Rios A, Oncina-Canovas A, Pérez-Farinós N, Nafria M, Casas R, Martínez-Diz S, Tojal-Sierra L, Am GP, Toledo E, Fernández-Carrión R, Bayón ÁM, Torres-Peña JD, Compañ-Gabucio L, Vázquez-Ruiz Z, Babio N, Fitó M, Salas-Salvadó J.

Aging Dis. 2024 Jul 21.

PMID: 39122449

FI: 7

Incidence of pregnancy related pulmonary embolism in Spain 2016-2021: an observational population-based retrospective study.

Rueda Camino JA, Azcoaga-Lorenzo A, Noguero-Meseguer R, Joya-Seijo D, Angelina-García M, Trujillo D, Miranda C, Barba-Martín R.

Rev Clin Esp (Barc). 2024 Jul 31.

PMID: 39094786

FI: 2,3

Systems Biology and Novel Biomarkers for the Early Detection of Diabetic Kidney Disease.

Villalvazo P, Villavicencio C, Gonzalez de Rivera M, Fernandez-Fernandez B, Ortiz A.

Nephron. 2024 Jul 29:1-7.

PMID: 39074450

FI: 2,3

Genetic testing for primary aldosteronism in SPAIN: Results from the SPAIN-ALDO Registry and review of the literature.

Araujo-Castro M, Ruiz-Sánchez JG, Gonzalvo C, Lamas C, Parra Ramírez P, Martín Marcos-Rojas P, Paja M, Robles Lázaro C, Michalapou T, Tous M, González M, Recio Córdova JM, Casteras A, Fernández-Álvarez P, Barca Tierno V, Mulatero P.

J Clin Endocrinol Metab. 2024 Jul 26.

PMID: 39058909

FI: 5

Genetic study in young patients with chronic kidney disease stage G5 from unknown etiology. The GENSEN study design.

Blasco M, Quiroga B, García-Aznar JM, Torra R, Ortiz A, de Sequera P, Grupo colaborativo GENSEN.

Nefrologia (Engl Ed). 2024.44(4):568-575.

PMID: 39054238

FI: 2

Bioimpedance analysis predicts worsening events in outpatients with heart failure and reduced ejection fraction.

Rodríguez-López C, Balaguer Germán J, Venegas Rodríguez A, Carda Barrio R, Gaebelt Slocker HP, Pello Lázaro AM, López Castillo M, Soler Bonafont B, Recio Vázquez M, Taibo Urquía M, González Piña M, González Parra E, Tuñón J, Aceña Á.

ESC Heart Fail. 2024 Jul 23.

PMID: 39044354

FI: 3,2

SARS-CoV-2 S Protein Reduces Cytoprotective Defenses and Promotes Human Endothelial Cell Senescence.

Villacampa A, Shamoon L, Valencia I, Morales C, Figueiras S, de la Cuesta F, Sánchez-Niño D, Díaz-Araya G, Sánchez-Pérez I, Lorenzo Ó, Sánchez-Ferrer CF, Peiró C.

Aging Dis. 2024 Jul 05.

PMID: 39012668

FI: 7

Polycystic ovary syndrome with a Sertoli-Leydig cell tumor: A case report.

Pérez de Arenaza Pozo V, Miguelez González M, Moya Orduñez LD.

Med Clin (Barc). 2024 Jul 11.

PMID: 38997929

FI: 2,6

Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.

Blasco M, Quiroga B, García-Aznar JM, Castro-Alonso C, Fernández-Granados SJ, Luna E, Fernández Fresnedo G, Ossorio M, Izquierdo MJ, Sanchez-Ospina D, Castañeda-Infante L, Mouzo R, Cao M, Besada-Cerecedo ML, Pan-Lizcano R, Torra R, Ortiz A, de Sequera P, GENSEN Study Investigators (Rosa Sánchez Hernández, Elena Goma).

Am J Kidney Dis. 2024 Jul 06.

PMID: 38972501

FI: 9,4

Heterogeneity in the incidence of kidney replacement therapy across Europe: a benchmarking tool to improve clinical practice.

Cordero L, Ortiz A.

Clin Kidney J. 2024 Jul.17(7):sfae155.

PMID: 38962250

FI: 3,9

Clinical outcomes in patients switching from agalsidase beta to migalastat: A Fabry Registry analysis.

Pisani A, Wilson KM, Batista JL, Kantola I, Ortiz A, Politei J, Al-Shaar L, Maski M, Crespo A, Ponce E, Linhart A.

J Inherit Metab Dis. 2024 Jul 04.

PMID: 38961737

FI: 4,2

Chronic kidney disease and the global public health agenda: an international consensus.

Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, Fliser D, Roy-Chaudhury P, Fontana M, Nangaku M, Wanner C, Malik C, Hradsky A, Adu D, Bavanandan S, Cusumano A, Sola L, Ulasi I, Jha V, American Society of Nephrology, European Renal Association, International Society of Nephrology.

Nat Rev Nephrol. 2024 Jul.20(7):473-485.

PMID: 38570631

FI: 28,7

More Adult Women than Men at High Cardiometabolic Risk Reported Worse Lifestyles and Self-Reported Health Status in the COVID-19 Lockdown.

Oncina-Cánovas A, Compañ-Gabucio L, Vioque J, Ruiz-Canela M, Corella D, Salas-Salvadó J, Fitó M, Martínez A, Alonso-Gómez ÁM, Wärnberg J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Álvarez-Pérez J, Bueno-Cavanillas A, Tur JA, Martín-Sánchez V, Esteve-Luque V, Delgado-Rodríguez M, Ortiz-Ramos M, Vidal J, Vázquez C, Daimiel L, Ros E, Razquin C, Paz-Graniel I, Sorlí JV, Castañer O, García-Rios A, Torres-Collado L, Fernández-Barceló O, Zulet MA, Rayó-Gago E, Casas R, Cano-Ibáñez N, Tojal-Sierra L, Simón-Frapolli VJ, Carlos S, Shyam S, Fernández-Carrión R, Goday A, Torres-Peña JD, González-Palacios S, Eguaras S, Babio N, Zomeño MD, García-de-la-Hera M.

Nutrients. 2024 Jun 24.16(13).

PMID: 38999747

FI: 4,8

Improving the nutritional care of oncology patients - Validation of a multidisciplinary protocol in the Spanish clinical setting.

García Almeida JM, Cornejo Pareja IM, Fernández Jiménez R, Lupiáñez Pérez Y, Molina Garrido MJ, Abreu Padín C, Alfaro Martínez JJ, Andreu Gosalbez MD, Argente Pla M, Arosa Carril V, Artero A, Cayón-Blanco M, Cuéllar Olmedo LÁ, de la Maza Pereg L, Diego Perojo E, Díez-Muñiz-Alique M, Diezhandino García P, Fernández de Bobadilla-Pascual B, Fernández Soto ML, Fuentes Tudanca S, Gil Gascón JM, Irles-Rocamora JA, Juan Rodríguez L, Llamazares Iglesias O, Losfablos Callau F, Manzano García G, Marco-Alacid C, Pérez Cobos M, Mendoza Sierra MªE, Olay Gayoso L, Olivares Alcolea J, Pereira Cunill JL, Pérez Alonso O, Rebollo Pérez MI, Ruiz Palomar JM, Silva Rodríguez JJ, Sorribes Carreras P, Vázquez Vizcaíno B, Wu-Xiong NY.

Nutr Hosp. 2024 Jun 20.

PMID: 38967309

FI: 1,2

Definition and evolution of the concept of sarcopenia.

Sanchez-Tocino ML, Cigarrán S, Ureña P, González-Casaus ML, Mas-Fontao S, Gracia-Iguacel C, Ortíz A, Gonzalez-Parra E.

Nefrologia (Engl Ed). 2024.44(3):323-330.

PMID: 38945744

FI: 2

Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation.

Aroca-Esteban J, Souza-Neto FV, Aguilar-Latorre C, Tribaldo-Torralbo A, González-López P, Ruiz-Simón R, Álvarez-Villareal M, Ballesteros S, de Ceniga MV, Landete P, González-Rodríguez Á, Martín-Ventura JL, de Las Heras N, Escribano Ó, Gómez-Hernández A.

Biochim Biophys Acta Mol Basis Dis. 2024 Jun 28.1870(7):167327.

PMID: 38945455

FI: 4,2

Loss of NLRP6 increases the severity of kidney fibrosis.

Valiño-Rivas L, Pintor-Chocano A, Carriazo SM, Sanz AB, Ortiz A, Sanchez-Niño MD.

J Cell Physiol. 2024 Jun 27.

PMID: 38934623

FI: 4,5

Renoprotective effect of Limonium duriusculum (de Girard) Kuntze via modulation of oxidative stress/ UPR markers and inflammation during cyclosporine-induced nephrotoxicity in rats.

Redouane-Salah A, Souad A, Kerkatou W, Wojnicki K, Ramos AM, Ortiz A, Kaminska B, Menad A.

Iran J Basic Med Sci. 2024.27(8):1023-1032.

PMID: 38911250

FI: 2,1

Changes in the epidemiology of kidney replacement therapy across Europe in 2020 - the first year of the COVID-19 pandemic: an ERA Registry study.

Kramer A, Jager KJ, Chesnaye NC, Kerschbaum J, Hommel K, Farnés JC, Alemán ST, Santamaria R, Finne P, Hemmelder MH, Åsberg A, Nitsch D, Ambühl P, Sørensen SS, Sánchez-Alvarez JE, Segelmark M, Resic H, Ots-Rosenberg M, Radunovic D, Palsson R, de Pablos CS, Arévalo OLR, Legeai C, Lausevic M, Bakkaloglu SA, Ortiz A, Stel VS.

Nephrol Dial Transplant. 2024 Jun 18.

PMID: 38889925

FI: 4,8

Bisphenol A in renal insufficiency: how long will it be used? Is it time to avoid it?

González-Parra E, Moreno-Gómez-Toledano R, Mas-Fontao S, Bosch RJ.

Nefrologia (Engl Ed). 2024.44(3):313-316.

PMID: 38876887

FI: 2

Effect of a nutritional intervention based on an energy-reduced Mediterranean diet on environmental impact.

Álvarez-Álvarez L, Rubín-García M, Vitelli-Storelli F, García S, Bouzas C, Martínez-González MÁ, Corella D, Salas-Salvadó J, Malcampo M, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, García Fernández C, Pintó X, Delgado-Rodríguez M, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, García-Arellano A, Martínez MÁ, Sorlí JV, Zomeño MD, García-Rios A, González-Palacios S, Monserrat-Mesquida M, Abete I, Colom Fernández A, Casas R, Cano Ibáñez N, Ugarriza L, Bernal-López MR, Bes-Rastrollo M, Paz-Graniel I, Asensio EM, Fitó M, Arenas Larriva AP, Oncina-Cánovas A, Vázquez Z, Fernández de la Puente M, Pérez-Vega A, Tur JA, Martín-Sánchez V.

Sci Total Environ. 2024 Jun 10.928:172610.

PMID: 38642762

FI: 8,2

Butyrate promotes kidney resilience through a coordinated kidney protective response in tubular cells.

Favero C, Pintor-Chocano A, Sanz A, Ortiz A, Sanchez-Niño MD.

Biochem Pharmacol. 2024 Jun.224:116203.

PMID: 38615919

FI: 5,3

Sixty years of European Renal Association (ERA) Registry data on kidney disease: visualizing differences in clinical practice.

Stel VS, Jager KJ, Ortiz A.

Nephrol Dial Transplant. 2024 May 31.39(6):897-900.

PMID: 38784973

FI: 4,8

Sixty years of European Renal Association (ERA) Registry data on kidney disease: visualizing differences in clinical practice.

Stel VS, Jager KJ, Ortiz A.

Clin Kidney J. 2024 May.17(5):sfae120.

PMID: 38783965

FI: 3,9

Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.

GBD 2021 Forecasting Collaborators (Collaborator: Ortiz A).

Lancet. 2024 May 18.403(10440):2204-2256.

PMID: 38762325

FI: 98,4

Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Risk Factors Collaborators (Collaborator: Ortiz A).

Lancet. 2024 May 18.403(10440):2162-2203.

PMID: 38762324

FI: 98,4

Cognitive decline related to chronic kidney disease as an exclusion factor from kidney transplantation: results from an international survey.

Farisco M, Blumblyte IA, Franssen C, Nitsch D, Zecchino I, Capasso G, Hafez G, COST CONNECT Action Collaborators (Collaborator: Ortiz A).

Clin Kidney J. 2024 May.17(5):sfae114.

PMID: 38745874

FI: 3,9

Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making.

Miquel-Rodríguez R, González-Toledo B, Pérez-Gómez MV, Cobo-Caso MÁ, Delgado-Mallén P, Estupiñán S, Cruz-Perera C, Díaz-Martín L, González-Rinne F, González-Delgado A, Torres A, Gaspari F, Hernández-Marrero D, Ortiz A, Porrini E, Luis-Lima S.

Int J Mol Sci. 2024 May 05.25(9).

PMID: 38732256

FI: 4,9

Dependency and frailty in the older haemodialysis patient.

Pereira M, Tocino MLS, Mas-Fontao S, Manso P, Burgos M, Carneiro D, Ortiz A, Arenas MD, González-Parra E.

BMC Geriatr. 2024 May 10.24(1):416.

PMID: 38730386

FI: 3,4

Time trends in preemptive kidney transplantation in Europe: an era registry study.

Kramer A, Boenink R, Mercado Vergara CG, Bell S, Kerschbaum J, Rodríguez Arévalo OL, Mazuecos A, de Vries APJ, Reisæter AV, Wong EHS, Lundgren T, Valentin MO, Alvarez FAO, Melilli E, Finne P, Segelmark M, Couchoud C, Sørensen SS, Ferraro PM, Arnol M, Arici M, Ortiz A, Jager KJ, Abramowicz D, Stel VS, Hellemans R.

Nephrol Dial Transplant. 2024 May 09.

PMID: 38724446

FI: 4,8

In vitro 3D co-culture model of human endothelial and smooth muscle cells to study pathological vascular remodeling.

San Sebastián-Jaraba I, Fernández-Gómez MJ, Blázquez-Serra R, Sanz-Andrea S, Blanco-Colio LM, Méndez-Barbero N.

Clin Investig Arterioscler. 2024 May 08.

PMID: 38724438

FI: 1,9

Impaired high-density lipoprotein function and endothelial barrier stability in severe anaphylaxis.

Fernandez-Bravo S, Canyelles M, Martín-Blázquez A, Borràs C, Nuñez-Borque E, Palacio-García L, Rodríguez Del Rio P, Betancor D, Gómez-López A, Sabaté Brescó M, Laguna JJ, Méndez-Barbero N, Rotllan N, Escolà-Gil JC, Esteban V.

J Allergy Clin Immunol. 2024 May 06.

PMID: 38718948

FI: 11,4

Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia.

Rodríguez-Rodríguez R, Hornum M, Rodríguez Rodríguez AE, Bevc S, Trevisani F, Fernández G, Hojs R, Fernández-Fernández B, Cases Corona CM, Cruzado JM, Quero M, Díaz MN, Bettiga A, Moreso F, Carro CG, Khazim K, Ghanem F, Ibernón M, Laranjinhia I, Mendonça L, Vieira MB, Feldt-Rasmussen B, Ortiz A, Bagi P, Sorensen CA, Morales E, Porrini E, DIABESITY working group of the European Renal Association.

Kidney Int Rep. 2024 May.9(5):1419-1428.

PMID: 38707823

FI: 5,7

Performances of acute kidney injury biomarkers vary according to sex.

Faguer S, Piedrafita A, Sanz AB, Siwy J, Mina IK, Alves M, Bousquet P, Marcheix B, Casemayou A, Klein J, Minville V, Breuil B, Ortiz A, Schanstra JP.

Clin Kidney J. 2024 May.17(5):sfae091.

PMID: 38699482

FI: 3,9

Decreased life expectancy: a health outcome not corrected by kidney replacement therapy that emphasizes the need for primary prevention of CKD.

Cordero L, Ortiz A.

Clin Kidney J. 2024 May.17(5):sfae053.

PMID: 38699481

FI: 3,9

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Diseases and Injuries Collaborators (Collaborator: Ortiz A).

Lancet. 2024 May 18.403(10440):2133-2161.

PMID: 38642570

FI: 98,4

Impact of hypochloremia as a prognostic factor in patients with heart failure, a retrospective cohort study.

de Peralta García P, Bolzoni M, Yebra Yebra M, Asenjo Martín M, Arrondo Turrado M, Domínguez Sepúlveda MA, Rueda Camino JA, Barba Martín R.

Rev Clin Esp (Barc). 2024 May.224(5):259-266.

PMID: 38588945

FI: 2,3

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Causes of Death Collaborators (Collaborator: Ortiz A).

Lancet. 2024 May 18.403(10440):2100-2132.

PMID: 38582094

FI: 98,4

Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Fertility and Forecasting Collaborators (Collaborator: Ortiz A).

Lancet. 2024 May 18.403(10440):2057-2099.

PMID: 38521087

FI: 98,4

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Demographics Collaborators (Collaborator: Ortiz A).

Lancet. 2024 May 18.403(10440):1989-2056.

PMID: 38484753

FI: 98,4

Impact of mediterranean diet promotion on environmental sustainability: a longitudinal analysis.

Álvarez-Álvarez L, Vitelli-Storelli F, Rubín-García M, García S, Bouzas C, Ruíz-Canela M, Corella D, Salas-Salvadó J, Fitó M, Martínez JA, Tojal-Sierra L, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Santos-Lozano JM, Serra-Majem L, Bueno-Cavanillas A, García-Fernández C, Esteve-Luque V, Delgado-Rodríguez M, Torrego-Ellacuría M, Vidal J, Prieto L, Daimiel L, Casas R, García Arellano A, Shyam S, González JI, Castañer O, García-Rios A, Ortiz Díaz F, Fernández AC, Sánchez-Villegas A, Morey M, Cano-Ibañez N, Sorto-Sánchez C, Bernal-López MR, Bes-Rastrollo M, Nishi SK, Coltell O, Zomeño MD, Peña-Orihuela PJ, Aparicio DV, Zulet MA, Vázquez Z, Babio N, Pérez KA, Tur JA, Martín-Sánchez V.

Public Health. 2024 May.230:12-20.

PMID: 38479163

FI: 3,9

Serum Biomarkers and Their Association with Myocardial Function and Exercise Capacity in Cardiac Transthyretin Amyloidosis.

Nieto-Roca L, Camblor Blasco A, Devesa A, Gómez-Talavera S, Balaguer-Germán J, Lumpuy-Castillo J, Pello AM, Dhier LM, Lapeña G, Jiménez LL, Lorenzo Ó, Tuñón J, Ibáñez B, Aceña Á.

J Cardiovasc Dev Dis. 2024 Apr 30.11(5).

PMID: 38786964

FI: 2,4

Paricalcitol Has a Potent Anti-Inflammatory Effect in Rat Endothelial Denudation-Induced Intimal Hyperplasia.

Baeza C, Pintor-Chocano A, Carrasco S, Sanz A, Ortiz A, Sanchez-Niño MD.

Int J Mol Sci. 2024 Apr 28.25(9).

PMID: 38732029

FI: 4,9

'The forgotten sex': gender disparities in kidney disease.

Stevens KI, Mallamaci F, Ortiz A, Bover J, Delanaye P, Torra R, Cozzolino M.

Clin Kidney J. 2024 Apr.17(4):sfad102.

PMID: 38628911

FI: 3,9

Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.

Stoumpos S, Crowe K, Sarafidis P, Barratt J, Bolignano D, Del Vecchio L, Małyszko J, Więcek A, Ortiz A, Cozzolino M.

Nephrol Dial Transplant. 2024 Apr 04.

PMID: 38573822

FI: 4,8

Feasibility of primary aldosteronism diagnosis in initial evaluation without medication withdrawal or confirmatory tests.

Ruiz-Sánchez JG, Fernández Sánchez Á, Meneses D.

Endocrine. 2024 Apr 03.

PMID: 38568364

FI: 3

Clinical and Genetic Analysis of Patients With TK2 Deficiency.

Ceballos F, Serrano-Lorenzo P, Bermejo-Guerrero L, Blázquez A, Quesada-Espinosa JF, Amigo J, Minguez P, Ayuso C, García-Arumí E, Muelas N, Jaijo T, Nascimento A, Galán-Rodriguez B, Paradas C, Arenas J, Carracedo A, Martí R, Martín MA, Domínguez-González C, for TK2d Spanish-Group.

Neurol Genet. 2024 Apr.10(2):e200138.

PMID: 38544965

FI: 3,6

Treatment of Chronic Heart Failure in Advanced Chronic Kidney Disease: The HAKA Multicenter Retrospective Real-World Study.

Quiroga B, Ortiz A, Núñez S, Kislikova M, González Sanchidrián S, Broseta JJ, Albines ZS, Escamilla Cabrera B, Rivero Viera Y, Rodriguez Santarelli D, Salanova Villanueva L, Lopez Rodriguez F, Cancho Castellano B, Ibáñez Cerezon M, Gutierrez Rivas CP, Aresté N, Campos Gutiérrez B, Ródenas Gálvez A, Glucksmann Pizá MC, Balda Manzanos S, Soldevila A, Rodríguez Gayo L, Moral Berrio E, Ortega Diaz M, Beltrán Catalán S, Puente García A, Ángel Rojas M, Sosa Barrios RH, Santana Zapatero H, Rangel Hidalgo G, Martinez Canet AM, Díez J, Cardiorenal Medicine Group (CaReSEN) of the Spanish Society of Nephrology.

Cardiorenal Med. 2024.14(1):202-214.

PMID: 38513622

FI: 2,4

Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease.

Balafa O, Fernandez-Fernandez B, Ortiz A, Dounousi E, Ekart R, Ferro CJ, Mark PB, Valdivielso JM, Del Vecchio L, Mallamaci F.

Clin Kidney J. 2024 Mar.17(3):sfae044.

PMID: 38638550

FI: 3,9

Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease.

Sánchez-Ospina D, Mas-Fontao S, Gracia-Iguacel C, Avello A, González de Rivera M, Mujika-Marticorena M, Gonzalez-Parra E.

J Clin Med. 2024 Mar 01.13(5).

PMID: 38592263

FI: 3

Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population.

Khoury N, Ángeles Martínez M, Nishi SK, Ángel Martínez-González M, Corella D, Castañer O, Alfredo Martínez J, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Manuel Santos-Lozano J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Cinza Sanjurjo S, Pintó X, Juan Gaforio J, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Sayon-Orea C, V Sorli J, Pérez-Vega KA, Garcia-Rios A, Ortiz-Díaz F, Gómez-Gracia E, Zulet MA, Chaplin A, Casas R, Salcedo-Bellido I, Tojal-Sierra L, Bernal-Lopez MR, Vazquez-Ruiz Z, Asensio EM, Goday A, Peña-Orihuela PJ, Signes-Pastor AJ, Garcia-Arellano A, Fitó M, Babio N, Salas-Salvadó J.

Environ Int. 2024 Mar 15.186:108565.

PMID: 38574403

FI: 10,3

Cardiac Rehabilitation Increases Plasma Klotho Levels.

Pello Lázaro AM, Villelabeitia Jaureguizar K, Franco Peláez JA, Venegas-Rodriguez A, Aceña Á, Kallmeyer A, Cánovas E, González-Casaus ML, Tarín N, Cristóbal C, Gutiérrez-Landaluce C, Huelmos A, González-Lorenzo Ó, Alonso J, López-Bescós L, Egido J, Mahillo-Fernández I, Lumpuy-Castillo J, Lorenzo Ó, Tuñón J.

J Clin Med. 2024 Mar 14.13(6).

PMID: 38541889

FI: 3

Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells.

Melones-Herrero J, Alcalá S, Ruiz-Cañas L, Benítez-Buelga C, Batres-Ramos S, Calés C, Lorenzo O, Perona R, Quiroga AG, Sainz B, Sánchez-Pérez I.

Commun Biol. 2024 Mar 22.7(1):353.

PMID: 38519773

FI: 5,2

Practical consensus for the treatment and follow-up of primary aldosteronism: a multidisciplinary consensus document.

Araujo-Castro M, Ruiz-Sánchez JG, Ramírez PP, Martín Rojas-Marcos P, Aguilera-Saborido A, Gómez Cerezo JF, López Lazareno N, Torregrosa ME, Gorrín Ramos J, Oriola J, Poch E, Oliveras A, Méndez Monter JV, Gómez Muriel I, Bella-Cueto MR, Mercader Cidoncha E, Runkle I, Hanzu FA.

Endocrine. 2024 Mar 20.

PMID: 38507182

FI: 3

CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes.

Schnell O, Barnard-Kelly K, Battelino T, Ceriello A, Larsson HE, Fernández-Fernández B, Forst T, Frias JP, Gavin JR, Giorgino F, Groop PH, Heerspink HJL, Herzig S, Hummel M, Huntley G, Ibrahim M, Itzhak B, Jacob S, Ji L, Kosiborod M, Lalic N, Macieira S, Malik RA, Mankovsky B, Marx N, Mathieu C, Müller TD, Ray K, Rodbard HW, Rossing P, Rydén L, Schumm-Draeger PM, Schwarz P, Škrha J, Snoek F, Tacke F, Taylor B, Jeppesen BT, Tesfaye S, Topsever P, Vilsbøll T, Yu X, Standl E.

Cardiovasc Diabetol. 2024 Mar 19.23(1):104.

PMID: 38504284

FI: 8,5

Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism.

Araujo-Castro M, Parra P, Martín Rojas-Marcos P, Paja Fano M, González Boillos M, Pascual-Corrales E, García Cano AM, Ruiz-Sanchez JG, Vicente Delgado A, Gómez Hoyos E, Ferreira R, García Sanz I, Recasens Sala M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, García Centeno R, Rebollo Román Á, Gracia Gimeno P, Robles Lázaro C, Morales-Ruiz M, Calatayud M, Furio Collao SA, Meneses D, Sampedro Nuñez M, Escudero Quesada V, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Del Castillo Tous M, Serrano Gotarredona J, Michalopoulou Alevras T, Moya Mateo EM, Hanzu FA.

Front Endocrinol (Lausanne). 2024.15:1336306.

PMID: 38495792

FI: 3,9

The role of anticomplement therapy in the management of the kidney allograft.

Kanbay M, Copur S, Yilmaz ZY, Baydar DE, Bilge I, Susal C, Kocak B, Ortiz A.

Clin Transplant. 2024 Mar.38(3):e15277.

PMID: 38485664

FI: 1,9

Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Soto-Catalán M, Opazo-Ríos L, Quiceno H, Lázaro I, Moreno JA, Gómez-Guerrero C, Egido J, Mas-Fontao S.

Int J Mol Sci. 2024 Mar 04.25(5).

PMID: 38474208

FI: 4,9

Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism.

Araujo-Castro M, Ruiz-Sánchez JG, Parra Ramírez P, Martín Rojas-Marcos P, Aguilera-Saborido A, Gómez Cerezo JF, López Lazareno N, Torregrosa Quesada ME, Gorrin Ramos J, Oriola J, Poch E, Oliveras A, Méndez Monter JV, Gómez Muriel I, Bella-Cueto MR, Mercader Cidoncha E, Runkle I, Hanzu FA, In representation of the following medical Spanish societies: Spanish Society of Endocrinology and Nutrition (SEEN), Spanish Society of Cardiology (SEC), Spanish Society of Nephrology (SEN), Spanish Society of Internal Medicine (SEMI), Spanish Radiology Society (SERAM), Spanish Society of Vascular and Interventional Radiology (SERVEI), Spanish Society of Laboratory Medicine (SEQC(ML), Spanish Society of Anatomic-Pathology, Spanish Association of Surgeons (AEC).

Endocrine. 2024 Mar 06.

PMID: 38448679

FI: 3

A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS.

Stel VS, Boenink R, Astley ME, Boerstra BA, Radunovic D, Skrunes R, Ruiz San Millán JC, Slon Roblero MF, Bell S, Ucio Mingo P, Ten Dam MAGJ, Ambühl PM, Resic H, Rodríguez Arévalo OL, Aresté-Fosalba N, Tort I Bardolet J, Lassalle M, Trujillo-Alemán S, Indridason OS, Artamendi M, Finne P, Rodríguez Camblor M, Nitsch D, Hommel K, Moustakas G, Kerschbaum J, Lausevic M, Jager KJ, Ortiz A, Kramer A.

Nephrol Dial Transplant. 2024 Mar 04.

PMID: 38439701

FI: 4,8

The error of estimated GFR in predialysis care.

Escamilla-Cabrera B, Luis-Lima S, Gallego-Valcarce E, Sánchez-Dorta NV, Negrín-Mena N, Díaz-Martín L, Cruz-Perera C, Hernández-Valles AM, González-Rinne F, Rodríguez-Gamboa MJ, Estupiñán-Torres S, Miquel-Rodríguez R, Cobo-Caso MÁ, Delgado-Mallén P, Fernández-Suárez G, González-Rinne A, Hernández-Barroso G, González-Delgado A, Torres-Ramírez A, Jiménez-Sosa A, Ortiz A, Gaspari F, Hernández-Marrero D, Porrini EL.

Sci Rep. 2024 Mar 03.14(1):5219.

PMID: 38433228

FI: 3,8

Consensus on the approach to hydrosaline overload in acute heart failure. SEMI/SEC/S.E.N. recommendations.

Llàcer P, Romero G, Trullàs JC, de la Espriella R, Cobo M, Quiroga B, Casado J, Slon-Roblero MF, Morales-Rull JL, Morgado JI, Ortiz A, Formiga F, Melendo-Viu M, de Sequera P, Recio A, Díez J, Manzano L, Núñez J.

Rev Esp Cardiol (Engl Ed). 2024 Mar 01.

PMID: 38432324

FI: 7,2

Analysis of the circumstances associated with death and predictors of mortality in Spanish adults with Down syndrome, 1997-2014.

Aparicio P, Alonso-Babarro A, Barba R, Moldenhauer F, Suárez C, de Asúa DR.

J Appl Res Intellect Disabil. 2024 Mar.37(2):e13187.

PMID: 38369309

FI: 2,1

Isolated hypoaldosteronism is a cause of hypovolemic but not euvolemic hyponatremia.

Ruiz-Sánchez JG, Calle-Pascual AL, Rubio-Herrera MÁ, De Miguel Novoa MP, Gómez-Hoyos E, Runkle I.

Endocr Connect. 2024 Mar 01.13(3).

PMID: 38288724

FI: 2,6

An unusual case of endotipsitis: persistent infection and migration to the right atrium of a transjugular intrahepatic portosystemic shunt (TIPS).

Calpena-Martínez S, Carrasco-Antón N, Cleary-Martín C, Hernández-Estefanía R, Esteban J, Cabello-Úbeda A, Petkova-Saiz E.

Eur J Clin Microbiol Infect Dis. 2024 Mar.43(3):623-626.

PMID: 38231308

FI: 3,7

The ERA Registry Annual Report 2021: a summary.

Boerstra BA, Boenink R, Astley ME, Bonthuis M, Abd ElHafeez S, Arribas Monzón F, Åsberg A, Beckerman P, Bell S, Cases Amenós A, Castro de la Nuez P, Ten Dam MAGJ, Debska-Slizien A, Gjorgjievski N, Giudotti R, Helve J, Hommel K, Idrizi A, Indriðason ÓS, Jarraya F, Kerschbaum J, Komissarov KS, Kozliuk N, Kravljaca M, Lassalle M, De Meester JM, Ots-Rosenberg M, Plummer Z, Radunovic D, Razvazhaieva O, Resic H, Rodríguez Arévalo OL, Santiuste de Pablos C, Seyahi N, Slon-Roblero MF, Stendahl M, Tolaj-Avdiu M, Trujillo-Alemán S, Ziedina I, Ziginskiene E, Ortiz A, Jager KJ, Stel VS, Kramer A.

Clin Kidney J. 2024 Feb.17(2):sfad281.

PMID: 38638342

FI: 3,9

Serum and Vitreous Levels of Placenta Growth Factor in Diabetic Retinopathy Patients: Correlation With Disease Severity and Optical Coherence Tomographic Parameters.

Mesquita J, Santos FM, Sousa JP, Vaz-Pereira S, Tavares-Ratado P, Neves A, Mesquita R, Tomaz CT.

Cureus. 2024 Feb.16(2):e54862.

PMID: 38533176

FI: 1

Inhibition of BRD4 Attenuates ER Stress-induced Renal Ischemic-Reperfusion Injury.

Diaz-Bulnes P, Rodríguez RM, Banon-Maneus E, Saiz ML, Bernet CR, Corte-Iglesias V, Ramirez-Bajo MJ, Lazo-Rodriguez M, Tamargo-Gómez I, Rodrigues-Diez RR, Sanz AB, Diaz-Corte C, Ruiz-Ortega M, Diekmann F, Aransay AM, Lopez-Larrea C, Suarez-Alvarez B.

Int J Biol Sci. 2024.20(5):1547-1562.

PMID: 38481808

FI: 8,2

Mechanisms of mesothelial cell response to viral infections: HDAC1-3 inhibition blocks poly(I:C)-induced type I interferon response and modulates the mesenchymal/inflammatory phenotype.

Trionfetti F, Montaldo C, Caiello I, Bontempi G, Terri M, Tiberi M, Marchant V, Domenici A, Menè P, Cordani M, Zwergel C, Prencipe G, Ruiz-Ortega M, Valente S, Mai A, Tripodi M, Strippoli R.

Front Cell Infect Microbiol. 2024.14:1308362.

PMID: 38476167

FI: 4,6

Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis.

Cruzado JM, Manonelles A, Rayego S, Doladé N, Amaya-Garrido A, Valera C, Guiteras R, Mosquera JL, Jung M, Codina S, Martínez-Valenzuela L, Draibe J, Couceiro C, Vigués F, Madrid Á, Florian MC, Ruíz-Ortega M, Sola A.

Kidney Int. 2024 Feb 28.

PMID: 38428734

FI: 14,8

Acute kidney injury (AKI): Spanish nomenclature also matters here.

Bover J, Romero-González G, Chávez-Iñiguez JS, Rizo-Topete L, Graterol F, Santandreu AV, Sanchez-Baya M, Díaz JM, Ortiz A, Poch E.

Nefrologia (Engl Ed). 2024.44(1):113-115.

PMID: 38418363

FI: 2

Prediabetes and Cardiometabolic Risk: The Need for Improved Diagnostic Strategies and Treatment to Prevent Diabetes and Cardiovascular Disease.

Lizarzaburu-Robles JC, Herman WH, Garro-Mendiola A, Galdón Sanz-Pastor A, Lorenzo O.

Biomedicines. 2024 Feb 04.12(2).

PMID: 38397965

FI: 3,9

Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.

Valencia I, Lumpuy-Castillo J, Magalhaes G, Sánchez-Ferrer CF, Lorenzo Ó, Peiró C.

Cardiovasc Diabetol. 2024 Feb 20.23(1):75.

PMID: 38378550

FI: 8,5

A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) Guidelines for the Management of Arterial Hypertension.

Sarafidis P, Schmieder R, Burnier M, Persu A, Januszewicz A, Halimi JM, Arici M, Ortiz A, Wanner C, Mancia G, Kreutz R.

Nephrol Dial Transplant. 2024 Feb 14.

PMID: 38365947

FI: 4,8

Sex-dependent expression of galectin-1, a cardioprotective β-galactoside-binding lectin, in human calcific aortic stenosis.

Jover E, Martín-Núñez E, Garaikoetxea M, Matilla L, Blanco-Colio LM, Pérez-Sáez JM, Navarro A, Fernández-Celis A, Gainza A, Álvarez V, Sádaba R, Tamayo I, Rabinovich GA, Martín-Ventura JL, López-Andrés N.

FASEB J. 2024 Feb 15.38(3):e23447.

PMID: 38329326

FI: 4,4

Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.

ElHafeez SA, Kramer A, Arici M, Arnol M, Åsberg A, Bell S, Belliere J, Corte CD, Fresnedo GF, Hemmelder M, Heylen L, Hommel K, Kerschbaum J, Naumović R, Nitsch D, Santamaria R, Finne P, Palsson R, Pippias M, Resic H, Rosenberg M, de Pablos CS, Segelmark M, Sørensen SS, Soler MJ, Vidal E, Jager KJ, Ortiz A, Stel VS.

Nephrol Dial Transplant. 2024 Feb 07.

PMID: 38327216

FI: 4,8

Hypertension and the kidney: an update.

Ruilope LM, Ortiz A, Ruiz-Hurtado G.

Eur Heart J. 2024 Feb 08.

PMID: 38326985

FI: 38,1

Increased prevalence of Kidney cysts in individuals carrying heterozygous COL4A3 or COL4A4 pathogenic variants.

Furlano M, Pilco-Teran M, Pybus M, Martínez V, Aza-Carmona M, Rius A, Pérez-Gomez V, Berná G, Mazo J, Hernández J, Fayos L, Viera E, Gich I, Vergara Pérez H, Gomá Garcés E, Albero Dolon JL, Ars E, Torra R.

Nephrol Dial Transplant. 2024 Feb 05.

PMID: 38317457

FI: 4,8

Glomerular hyperfiltration as a therapeutic target for CKD.

Kanbay M, Copur S, Bakir CN, Covic A, Ortiz A, Tuttle KR.

Nephrol Dial Transplant. 2024 Feb 02.

PMID: 38308513

FI: 4,8

The blood urea nitrogen to creatinine ratio in chronic heart failure: 'When the past is prologue'.

de la Espriella R, Ortiz A, Núñez J.

Eur J Heart Fail. 2024 Feb.26(2):257-259.

PMID: 38239035

FI: 16,9

Modulation of miR-29a and miR-29b Expression and Their Target Genes Related to Inflammation and Renal Fibrosis by an Oral Nutritional Supplement with Probiotics in Malnourished Hemodialysis Patients.

Sasso CV, Lhamyani S, Hevilla F, Padial M, Blanca M, Barril G, Jiménez-Salcedo T, Martínez ES, Nogueira Á, Lago-Sampedro AM, Olveira G.

Int J Mol Sci. 2024 Jan 17.25(2).

PMID: 38256206

FI: 4,9

Late-onset methylmalonic acidemia and homocysteinemia (cblC disease): systematic review.

Arhip L, Brox-Torrecilla N, Romero I, Motilla M, Serrano-Moreno C, Miguélez M, Cuerda C.

Orphanet J Rare Dis. 2024 Jan 20.19(1):20.

PMID: 38245797

FI: 3,4

SARS-CoV-2 S protein activates NLRP3 inflammasome and deregulates coagulation factors in endothelial and immune cells.

Villacampa A, Alfaro E, Morales C, Díaz-García E, López-Fernández C, Bartha JL, López-Sánchez F, Lorenzo Ó, Moncada S, Sánchez-Ferrer CF, García-Río F, Cubillos-Zapata C, Peiró C.

Cell Commun Signal. 2024 Jan 15.22(1):38.

PMID: 38225643

FI: 8,2

Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry.

Parra Ramírez P, Martín Rojas-Marcos P, Paja Fano M, González-Boillos M, Pascual-Corrales E, García Cano AM, Ruiz-Sanchez JG, Vicente Delgado A, Gómez Hoyos E, Ferreira R, García Sanz I, Recasens Sala M, Barahona San Millan R, Picón César MJ, Díaz Guardiola P, Perdomo CM, Manjón-Miguélez L, Rebollo Román Á, Robles Lázaro C, Morales-Ruiz M, Calatayud M, Andree Furio Collao S, Meneses D, Sampedro-Nuñez MA, Mena Ribas E, Sanmartín Sánchez A, Gonzalvo Diaz C, Lamas C, Guerrero-Vázquez R, Del Castillo Tous M, Serrano Gotarredona J, Michalopoulou Alevras T, Tenés Rodrigo S, Roa Chamorro R, Jaen Aguila F, Moya Mateo EM, Hanzu FA, Araujo-Castro M.

High Blood Press Cardiovasc Prev. 2024 Jan.31(1):43-53.

PMID: 38225508

FI: 3,1

Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population.

Baenas I, Camacho-Barcia L, Granero R, Razquin C, Corella D, Gómez-Martínez C, Castañer-Niño O, Martínez JA, Alonso-Gómez ÁM, Wärnberg J, Vioque J, Romaguera D, López-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem JL, Cano-Ibáñez N, Tur JA, Martín-Sánchez V, Pintó X, Gaforio JJ, Matía-Martín P, Vidal J, Vázquez C, Daimiel L, Ros E, Jiménez-Murcia S, Dalsgaard S, Garcia-Arellano A, Babio N, Sorli JV, Lassale C, García-de-la-Hera M, Gómez-García E, Zulet MA, Konieczna J, Martín-Peláez S, Tojal-Sierra L, Basterra-Gortari FJ, de Las Heras-Delgado S, Portoles O, Muñoz-Pérez MÁ, Arenas-Larriva AP, Compañ-Gabucio L, Eguaras S, Shyam S, Fitó M, Baños RM, Salas-Salvadó J, Fernández-Aranda F.

J Endocrinol Invest. 2024 Jan 13.

PMID: 38218741

FI: 3,9

Uromodulin biology.

Karagiannidis AG, Theodorakopoulou MP, Pella E, Sarafidis PA, Ortiz A.

Nephrol Dial Transplant. 2024 Jan 11.

PMID: 38211973

FI: 4,8

Biopsy-proven giant cell arteritis in an elderly woman diagnosed 11 years earlier with microscopic polyangiitis: two different vasculitis in the same patient separated in time.

Fernandez-Prado R, García-Fernández A, Avello A, Heras-Recuero E, Cannata P, González-Gay MA.

Clin Exp Rheumatol. 2024 Jan 02.

PMID: 38179718

FI: 3,4

Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation.

Ruiz-Rodríguez MJ, Oller J, Martínez-Martínez S, Alarcón-Ruiz I, Toral M, Sun Y, Colmenar Á, Méndez-Olivares MJ, López-Maderuelo D, Kern CB, Nistal JF, Evangelista A, Teixido-Tura G, Campanero MR, Redondo JM.

EMBO Mol Med. 2024 Jan.16(1):132-157.

PMID: 38177536

FI: 9

Consensus document on the management of hyperkalemia.

Ortiz A, Galán CDA, Carlos Fernández-García J, Cerezo JG, Ochoa RI, Núñez J, Gutiérrez FP, Navarro-González JF.

Nefrologia (Engl Ed). 2023.43(6):765-782.

PMID: 38169239

FI: 2

Título: MAKIPS-Calculadora FRA-H.

Código identificativo: 059cdd34360ef63525302ccea3b33e00f2f89ffb1b916f0f81adb0df26c41c34

Centro: HUFJD

Autor/es: Alberto Ortiz Arduan.